Novel CRISPR-Cas9 screening enables discovery of new targets to … – Medical Xpress
Medical Xpress |
Novel CRISPR-Cas9 screening enables discovery of new targets to …
Medical Xpress A novel screening method developed by a team at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing … |
|
FDA Advisory Committee Recommends Approval of CAR–T Cell Therapy and Two New Biosimilars
Lexology (registration) The FDA’s Oncologic Drug Advisory Committee (“ODAC”) held a public meeting on Wednesday, July 12, 2017, to consider Novartis’ biologic license application (BLA 125646) for tisagenlecleucel (CTL019), an investigational chimeric antigen receptor T cell … |
IFLScience |
Promising Treatment For Leukemia Leads To Remission In Clinical …
IFLScience An exciting therapy for leukemia once again shines a light on its efficacy – this time, nearly 71 percent of terminal leukemia patients saw their tumors sh. |
LancasterOnline |
McCaskey grad writes new book on CRISPR and genome engineering
LancasterOnline Now, the McCaskey High graduate has co-written a new book about gene editing and CRISPR. “A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution” was written by microbiologist Jennifer Doudna and Sternberg. The book … |
LancasterOnline |
McCaskey grad writes new book on CRISPR and genome engineering
LancasterOnline Now, the McCaskey High graduate has co-written a new book about gene editing and CRISPR. “A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution” was written by microbiologist Jennifer Doudna and Sternberg. The book … |
Independent.ie |
‘Tragic and avoidable’ – Hospital apologises for death of woman after stem cell operation
Independent.ie Ms Kozyra needed the transplant having been diagnosed at Belfast City Hospital with a bone marrow stem cell disorder. A family match could not be found for her and Northern Ireland does not carry out unrelated donor bone marrow transplants. So she was … |
FierceBiotech |
News of Note—Dodgy stem cell clinics; New CMO for Context; UroGen payday
FierceBiotech In an article published today in the journal Regenerative Medicine, it turns out that the federal clinical-trials database ClinicalTrials.gov has allowed 18 ostensible clinical trials of unregulated stem cell therapies, that patients must to pay to … |
FierceBiotech |
News of Note—Dodgy stem cell clinics; New CMO for Context; UroGen payday
FierceBiotech In an article published today in the journal Regenerative Medicine, it turns out that the federal clinical-trials database ClinicalTrials.gov has allowed 18 ostensible clinical trials of unregulated stem cell therapies, that patients must to pay to … |